A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
This study has been completed.
Study NCT01407874
Information provided by BioCryst Pharmaceuticals
First Received on August 1, 2011.
Last Updated on September 18, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
